<DOC>
	<DOCNO>NCT02578459</DOCNO>
	<brief_summary>The purpose study compare efficacy pain treatment ITDD efficacy pain treatment CMM patient pancreatic cancer pain .</brief_summary>
	<brief_title>A Pilot Study Evaluate Efficacy ITDD vs. CMM Treatment Pancreatic Cancer Pain</brief_title>
	<detailed_description>This study non-randomized , open-label , single-center study compare efficacy pain treatment ITDD efficacy pain treatment CMM patient suffer pancreatic cancer pain . There two treatment group : Study group ( ITDD ) : These subject Prometra System implant managed appropriate drug regimen treat pain . Systemic analgesic prescribe group . Control group ( CMM ) : These subject treat CMM treat pain . A maximum 30 subject ( maximum 15 treatment group ) may enrol study one study center .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>1 . Patient Stage IV pancreatic cancer . 2 . Patient agrees treat oncologist anesthesiologist study . 3 . Patient agree obtain pain medication physician study . 4 . Patient least 22 year age . 5 . Investigator considers patient able willing fulfill study requirement . 6 . Patient able understand study provide write informed consent participate study . 1 . Patient meet contraindication use Prometra Programmable Infusion System ( patient ITDD group ) . 2 . Patient enrol another clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Cancer pain</keyword>
	<keyword>Intrathecal therapy</keyword>
	<keyword>Pain</keyword>
	<keyword>Pancreatic cancer</keyword>
</DOC>